Clinical Trial Update: Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial assessing BEZ235 alone or with RAD001 for reducing respiratory tract infections in the elderly. The study is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• BEZ235 (dactolisib)
• RAD001 (everolimus)

Snippet

Sponsor: Restorbio Inc. | Conditions: Respiratory Tract Infections | Phase 2 | Status: ACTIVE_NOT_RECRUITING